STAVUDINE — all Canadian products
5 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is STAVUDINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02237009 | ZERIT | BRISTOL-MYERS SQUIBB CANADA | Powder For Solution | Oral | STAVUDINE 1 MG | Cancelled Pre Market | |
| 02216086 | ZERIT - CAP 15MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | STAVUDINE 15 MG | Cancelled Post Market | |
| 02216094 | ZERIT - CAP 20MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | STAVUDINE 20 MG | Cancelled Post Market | |
| 02216108 | ZERIT - CAP 30MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | STAVUDINE 30 MG | Cancelled Post Market | |
| 02216116 | ZERIT - CAP 40MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | STAVUDINE 40 MG | Cancelled Post Market |
Browse other molecules: